Loading...
Loading...
Jefferies initiated coverage on
Sarepta Therapeutics IncSRPT with a Hold rating. The target price for Sarepta Therapeutics is set to $28. Sarepta Therapeutics shares closed at $24.23 on Thursday.
Analysts at BMO Capital initiated initiated coverage on
TransCanada Corporation (USA)TRP with a Outperform rating. TransCanada shares closed at $34.24 on Thursday.
Jefferies initiated coverage on
PTC Therapeutics, Inc. PTCT with a Hold rating. The target price for PTC Therapeutics is set to $26. PTC Therapeutics shares closed at $24.99 on Thursday.
Analysts at Brean Capital initiated coverage of
Xtant Medical Holdings IncXTNT with a Buy rating. The target price for Xtant Medical Holdings is set to $10. Xtant Medical Holdings shares closed at $3.30 on Thursday.
Analysts at Jefferies initiated coverage on
Ignyta Inc RXDX with a Buy rating. The target price for Ignyta is set to $18. Ignyta shares closed at $10.02 on Thursday.
Jefferies initiated coverage on
Alnylam Pharmaceuticals, Inc.ALNY with a Buy rating. The target price for Alnylam Pharmaceuticals is set to $107. Alnylam Pharmaceuticals shares closed at $75.37 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in